Citation tools
"Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide." Journal of Nuclear Medicine
(2021):
jnumed.120.259069.
Web. 08 Mar. 2021.